Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary

Garry R Barton1, Lisa Irvine1, Marcus Flather1

  • 1Norwich Medical School, University of East Anglia, Norwich, UK.

Insights

Complete revascularization during ST-segment elevation myocardial infarction is more effective and cost-effective than treating only the infarct-related artery. This approach reduces major adverse cardiac events and hospital costs, offering better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Interventional Cardiology

Background:

  • ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease often require percutaneous coronary intervention (P-PCI).
  • The optimal revascularization strategy, complete versus infarct-related artery (IRA) only, remains an area of economic and clinical evaluation.

Purpose of the Study:

  • To determine the cost-effectiveness of complete revascularization versus IRA-only P-PCI in STEMI patients with multivessel disease.
  • To compare major adverse cardiac events (MACEs) and quality-adjusted life-years (QALYs) between the two strategies.

Main Methods:

  • Economic evaluation of a multicenter randomized trial with 12-month follow-up.
  • Estimation of overall hospital costs, including P-PCI procedures, hospital stay, and re-admissions.
  • Assessment of MACEs and QALYs using the EuroQol five-dimensional questionnaire.

Main Results:

  • Complete revascularization was associated with a mean cost reduction of -£215.96 and a reduction of 0.170 MACEs per patient.
  • A gain of 0.011 QALYs was observed with complete revascularization.
  • The probability of complete revascularization being cost-effective was 72.0% at a willingness-to-pay threshold of £20,000 per QALY.

Conclusions:

  • Complete revascularization at index admission is more effective and cost-effective for STEMI patients with multivessel disease.
  • This strategy dominates IRA-only treatment, showing lower costs and improved clinical outcomes.
  • While the results suggest a clear benefit, some uncertainty remains in the decision-making process.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
443
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
338